Kazuhiro Noguchi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Diffuse Large B Cell Lymphoma

Epidermal Growth Factor Receptor

Lipopolysaccharide Induced

Top Venues

Pediatric blood & cancer

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuhiro Noguchi, Yasuhiro Ikawa
Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review. Cancers 15 (24) (2023)
Toshihiro Fujiki, Yuta Sakai, Yasuhiro Ikawa, Mika Takenaka, Kazuhiro Noguchi, Rie Kuroda, Takatoshi Abe, Kozo Nomura, Seisho Sakai, Taizo Wada
Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib. Pediatric blood & cancer 70 (4) (2023)
Kazuhiro Noguchi, Yasuhiro Ikawa, Mika Takenaka, Yuta Sakai, Toshihiro Fujiki, Rie Kuroda, Hiroko Ikeda, Takatoshi Abe, Seisho Sakai, Taizo Wada
Acquired L1196M ALK mutation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma during alectinib administration. EJHaem 4 (1) (2023)
Toshihiro Fujiki, Yuta Sakai, Yasuhiro Ikawa, Mika Takenaka, Kazuhiro Noguchi, Rie Kuroda, Takatoshi Abe, Kozo Nomura, Seisho Sakai, Taizo Wada
Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib. Pediatric blood & cancer (2023)
Toshihiro Fujiki, Yuta Sakai, Yasuhiro Ikawa, Mika Takenaka, Kazuhiro Noguchi, Rie Kuroda, Takatoshi Abe, Kozo Nomura, Seisho Sakai, Taizo Wada
Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib. Pediatric blood & cancer 70 (4) (2023)
Kazuhiro Noguchi, Yasuhiro Ikawa
Strategy for Pediatric Patients with Relapsed or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: A Review. Cancers 15 (24) (2023)
Toshihiro Fujiki, Yuta Sakai, Yasuhiro Ikawa, Mika Takenaka, Kazuhiro Noguchi, Rie Kuroda, Takatoshi Abe, Kozo Nomura, Seisho Sakai, Taizo Wada
Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion successfully treated by alectinib. Pediatric blood & cancer 70 (4) (2023)
Kazuhiro Noguchi, Yasuhiro Ikawa, Mika Takenaka, Yuta Sakai, Toshihiro Fujiki, Rie Kuroda, Hiroko Ikeda, Takatoshi Abe, Seisho Sakai, Taizo Wada
Acquired L1196M ALK mutation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma during alectinib administration. EJHaem 4 (1) (2023)
Kazuhiro Noguchi, Yasuhiro Ikawa, Mika Takenaka, Yuta Sakai, Toshihiro Fujiki, Rie Kuroda, Taizo Wada
Characterisation of two tumour cell populations in the small cell variant of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. British journal of haematology (2021)